Trial no.:
|
PACTR201211000432357 |
Date of Approval:
|
08/10/2012 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Value of methylprednisolone infusion in patients wtih vertebral deposits |
Official scientific title |
Pre-emptive value of methylpredinsolone intravenous infusion in patients with vertebral deposits. Double blinded randomized study |
Brief summary describing the background
and objectives of the trial
|
One hundred twenty patients with vertebral metastases received short course external beam radiotherapy as high-voltage radiation with 6-Mev-Linear-Accelerator , 60 patients received in addition to the short course radiotherapy preemptive methylprednisolone infusion 5 mg/kg the day just before initiation of radiotherapy (grp1) and another 60 patients received short course radiotherapy without pretreatment methylprednisolone infusion (grp2). Brief Pain Inventory (BPI),incidence of pain flare duri |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Musculoskeletal Diseases,Vertebral metasteses |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Supportive care |
Anticipated trial start date |
01/10/2012 |
Actual trial start date |
01/10/2012 |
Anticipated date of last follow up |
31/12/2012 |
Actual Last follow-up date |
31/12/2012 |
Anticipated target sample size (number of participants) |
120 |
Actual target sample size (number of participants) |
|
Recruitment status |
Not yet recruiting |
Publication URL |
|
|